Q2 2026 · Form 13F Ledger数据来源:SEC EDGAR  
H

HOLDER.TOP

谁持有什么——美股机构持仓的季度账本。
EN · 简 · 繁
机构 / Elmind Capital, LP
Form 13F · Q2 2026

Elmind Capital, LP

CIK 2052213申报日 2026-08-1413F-HR 在 EDGAR 查看原始申报 ↗
$4.0亿
申报组合市值
35
持仓数量
3
Quarters on record
Top 50
持仓数量

Elmind Capital, LP——持仓

共 35 个持仓中的前 35 名,按申报市值排名。股数变动与上一季度对比。
#证券股数股数环比市值占其组合
1COGT Cogent Biosciences Inc1.2M+0.0%$4531万11.4%
2SNDX Syndax Pharmaceuticals Inc1.9M+0.0%$4055万10.2%
3CLDX Celldex Therapeutics Inc New990,000+14.5%$3684万9.3%
4RLAY Relay Therapeutics Inc1.5M+172.9%$2742万6.9%
5PCVX Vaxcyte Inc452,340+42.9%$2629万6.6%
6VERA Vera Therapeutics Inc436,518−9.5%$1873万4.7%
7PHVS Pharvaris N V525,750+10.5%$1818万4.6%
8VRDN Viridian Therapeutics Inc984,931+84.1%$1809万4.5%
9CTMX Cytomx Therapeutics Inc.4.5M+0.0%$1706万4.3%
10TVTX Travere Therapeutics Inc292,600+64.8%$1662万4.2%
11LEGN Legend Biotech Corp570,569—$1648万4.1%
12BEAM Beam Therapeutics Inc476,338+0.0%$1635万4.1%
13CGEM Cullinan Therapeutics Inc690,000+30.2%$1256万3.2%
14NRIX Nurix Therapeutics Inc460,000+0.0%$1116万2.8%
15KRYS Krystal Biotech Inc22,000+0.0%$818万2.1%
16UTHR United Therapeutics Corp Del15,000+0.0%$813万2.0%
17SMMT Summit Therapeutics Inc493,820—$719万1.8%
18INSM Insmed Inc65,000—$693万1.7%
19BCRX Biocryst Pharmaceuticals Inc520,000−48.0%$520万1.3%
20MBX Mbx Biosciences Inc91,000−56.9%$502万1.3%
21PTGX Protagonist Therapeutics Inc38,000+0.0%$466万1.2%
22URGN Urogen Pharma Ltd120,000−45.5%$442万1.1%
23DBVT Dbv Technologies S A265,000+0.0%$435万1.1%
24ALMS Alumis Inc130,000+0.0%$366万0.9%
25SUPN Supernus Pharmaceuticals70,000+250.0%$326万0.8%
26BMRN Biomarin Pharmaceutical Inc47,000+0.0%$269万0.7%
27IMCR Immunocore Hldgs Plc81,143+39.3%$258万0.6%
28AMLX Amylyx Pharmaceuticals Inc112,000+0.0%$201万0.5%
29ALEC Alector Inc900,000+0.0%$181万0.5%
30SEPN Septerna Inc49,444—$166万0.4%
31DSGN Design Therapeutics Inc107,900−48.1%$156万0.4%
32STRO Sutro Biopharma Inc32,037—$106万0.3%
33WVE Wave Life Sciences Ltd177,846+0.0%$103万0.3%
34TYRA Tyra Biosciences Inc20,000−94.3%$64万0.2%
35ENGN Engene Therapeutics Inc210,000—$36万0.1%
来源:经 SEC EDGAR 的 Form 13F 申报。持仓截至 2026 年 6 月 30 日。期权(看涨/看跌)不计入股数。